Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2009. Start Trial.
Date Value
November 13, 2026 34.93B
November 12, 2026 35.16B
November 11, 2026 36.47B
November 10, 2026 36.59B
November 09, 2026 37.65B
November 06, 2026 36.32B
November 05, 2026 35.77B
November 04, 2026 37.23B
November 03, 2026 37.48B
November 02, 2026 37.11B
October 30, 2026 38.43B
October 29, 2026 38.08B
October 28, 2026 38.57B
October 27, 2026 30.81B
October 26, 2026 30.82B
October 23, 2026 30.27B
October 22, 2026 27.94B
October 21, 2026 27.67B
October 20, 2026 27.36B
October 19, 2026 27.01B
October 16, 2026 26.09B
October 15, 2026 26.60B
October 14, 2026 26.02B
October 13, 2026 25.83B
October 12, 2026 26.32B
Date Value
October 09, 2026 26.13B
October 08, 2026 25.51B
October 07, 2026 25.88B
October 06, 2026 26.58B
October 05, 2026 27.00B
October 02, 2026 24.71B
October 01, 2026 24.58B
September 30, 2026 25.28B
September 29, 2026 25.01B
September 28, 2026 24.88B
September 25, 2026 24.86B
September 24, 2026 24.56B
September 23, 2026 24.52B
September 22, 2026 24.80B
September 21, 2026 24.48B
September 18, 2026 24.51B
September 17, 2026 24.39B
September 16, 2026 24.31B
September 15, 2026 24.16B
September 14, 2026 23.26B
September 11, 2026 23.16B
September 10, 2026 23.01B
September 09, 2026 23.50B
September 08, 2026 23.79B
September 04, 2026 23.83B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AbbVie, Inc. 591.64B
Incyte Corp. 20.86B
Ascendis Pharma A/S 17.48B
Zealand Pharma A/S 407.51M
Bavarian Nordic A/S 2.199B